You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

28 July 2016

Hepatitis C among drug users in Europe is high but there is cause for optimism

Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.

11 July 2016

Feasible to prescribe ART to emergency department patients with suspected acute HIV infection

Pilot study demonstrates that delivering antiretroviral treatment to individuals presenting to emergency departments with suspected acute HIV infection is highly feasible,

03 June 2016

Injectable opiate substitution treatment approved by FDA

An injectable version of the opiate substitution treatment (OST) buprenorphine – which is delivered through an implant – has been approved for use in the USA by the Food and Drug Administration (FDA).

10 May 2016

Hepatitis C becomes the leading infectious disease killer in the USA

Hepatitis C (HCV) has become the leading infectious disease killer in the United States of America (USA), exceeding the combined total deaths of 60 other diseases, including HIV and tuberculosis. HCV is a major co-morbidity for people living with HIV.

05 May 2016

USA: HIV incidence declining, but not enough to reach targets

The number of new HIV infections in the USA has fallen by 11% between 2010 and 2015, however the rate of decline falls far short of the goals set in the 2010-2015 National HIV/AIDS Strategy (NHAS).

18 April 2016

Worries about ‘super gonorrhoea’ in England

Cases of antibiotic resistant gonorrhoea are on the rise in England and spreading across the country, according to a statement issued by Public Health England (PHE) on Sunday.

23 March 2016

Advocates left shocked by NHS England decision against providing PrEP

National Health Service (NHS) England has decided against providing pre-exposure prophylaxis (PrEP) for HIV-negative people at a high risk of HIV, sparking outrage among a number of HIV charities and service providers in the UK.